XOMA Royalty (XOMA) Enterprise Value Growth (5y) (2015 - 2026)
XOMA Royalty (XOMA) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,769.80 Bn | 1,769.74 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.64 Bn | 468.85 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.74 Bn | 116.49 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.73 Bn | 62.97 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.10 Bn | 62.10 Bn | - |
| 7 | Argenx Se | 54.68 Bn | 49.49 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.13 Bn | 35.12 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.21 Bn | 36.21 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13% |
| Dec 31, 2025 | 5.91% |
| Sep 17, 2025 | -18.75% |
| Jun 30, 2025 | 17.73% |
| Mar 31, 2025 | -11.69% |
| Dec 31, 2024 | -7.91% |
| Sep 30, 2024 | 34.47% |
| Jun 30, 2024 | -27.85% |
| Mar 31, 2024 | -23.01% |
| Dec 31, 2023 | -27.37% |
| Sep 30, 2023 | -3.45% |
| Jun 30, 2023 | 3.87% |
| Mar 31, 2023 | -1.23% |
| Dec 31, 2022 | 62.21% |
| Sep 30, 2022 | -10.52% |
| Jun 30, 2022 | -46.36% |
| Mar 31, 2022 | -34.53% |
| Dec 31, 2021 | -29.95% |
| Sep 30, 2021 | -28.48% |
| Jun 30, 2021 | -18.83% |